Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
Karuna Kumar,Senior Consultant at Yashoda Hospitals, shared a post on LinkedIn:
“Interesting trial from Gambia on treating iron deficiency in children.
The problem:
- Ferrous sulfate tablets work poorly in kids with chronic inflammation.
- Poor absorption.
- GI upset.
- Low compliance.
This study tested heme iron polypeptide (HIP) against standard ferrous salts.
Heme iron is the form found in meat.
It absorbs through a different pathway than regular iron supplements.
Doesn’t get blocked by inflammation the same way.
The results?
Both raised hemoglobin. But heme iron had better tolerability and absorption in kids with high inflammation markers.
Why this matters for India:
We have millions of children with chronic infections, parasites, and subclinical inflammation.
Standard iron tablets often fail them.
Heme iron supplements exist but are underused. They cost more, yes. But if regular iron isn’t working after 2-3 months, it’s worth considering.
Not every anemia responds to the cheapest option. Sometimes you need to match the treatment to the patient.”
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America
-
Apr 22, 2026, 07:02Michael Wong: Predicting Blood Clots is a Patient Safety Issue
-
Apr 22, 2026, 07:02Rich Gorman: The Role of Inquiry Findings in Shaping Professional Memory and Learning
-
Apr 22, 2026, 06:01Kathaleen Schnur: Global Perspectives on Psychosocial Support in Hemophilia Care
-
Apr 22, 2026, 05:43Maia Meier: A Journey to Raise Awareness for Women with Bleeding Disorders
-
Apr 22, 2026, 05:41Moustafa Abdou: Diagnostic Challenges in Pediatric Hematology
-
Apr 22, 2026, 04:43Ifeanyichukwu Ifechidere: The Critical Role of Calibrator Specificity in Anticoagulation Monitoring
-
Apr 22, 2026, 04:13Ilenia Calcaterra: Clinical Relevance of Persistent Pain in Emicizumab-Treated Haemophilia A